BioSpace News Archive

Oxurion NV (Euronext Brussels: OXUR) (the “Company” or “Oxurion”), today announced that, pursuant to Belgian transparency legislation1, it had received two transparency notifications following the closing of its private placement, which was announced on March 7, 2022.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, the European Organisation for Research and Treatment of Cancer (EORTC) and the European Thoracic Oncology Platform (ETOP) today announced results from the pivotal Phase 3 KEYNOTE-091 trial, also known as EORTC-1416-LCG/ETOP-8-15 – PEARLS.

Over the years, society has changed and thus, the environment. People are now more open to accepting assisted reproductive technology.

NeuPath Health Inc., owner and operator of a network of clinics delivering category-leading chronic pain treatment, announced its financial and operating results for the three months and year ended December 31, 2021.

Moderna, Inc. announced that it has submitted a request to the U.S. Food and Drug Administration for an amendment to the emergency use authorization to allow for a fourth dose of its COVID-19 vaccine in adults 18 years of age and older who have received an initial booster of any of the authorized or approved COVID-19 vaccines.

Albany NY, United States: Transparency Market Research has published a new report titled, “Kidney Dialysis Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Eurofins Viracor, LLC, a leader in testing for infectious disease, immunology, and allergy, announced today that it has entered into an exclusive license agreement with Cornell University to commercialize several ground-breaking and novel assays aimed at transforming the clinical management of COVID-19 and transplant patients impacted from tissue damage and infections.

Agilex Biolabs Pty Ltd has unveiled its new building with a ribbon cutting ceremony by The Honourable Stephen Patterson MP Minister for Trade and Investment at 12:30pm on Thursday 17 February 2022 at 31 Dalgleish street Thebarton South Australia 5031.

The innate as well as adaptive immune response both has critical roles to fight against cancer. However, studies have shown that most effective tumor killing occurs when these work mutually.

Today, Health Canada authorized the use of the Moderna Spikevax (50 mcg) COVID-19 vaccine in children 6 to 11 years of age.